-
of the immune system in retinal degenerative disease. We utilize induced pluripotent stem cells, human donor tissue and mouse models of retinal degeneration to study the role of monocyte derived macrophages in
-
therapies for such cancers, and test them in cellular and animal models. If you thrive in a collaborative environment and have a keen interest in both imaging and treatment of cancer, this role is perfect
-
. Desirable Qualifications: Desirable Qualifications: Laboratory skills:in vitro and in vivo studies, flow cytometry, andtechniques in molecular biology Experience with mouse models. Competency in SolidWorks
-
: Desirable Qualifications: Laboratory skills: in vitro and in vivo studies, nanoparticle drug delivery, and RNA therapeutics Experience with mouse models. Competency in SolidWorks, Graphpad, and Adobe
-
on human medicine by studying the impact of novel therapy, screening, or treatment models. Several projects are available and focus on topics such as a pilot project studying lung cancer screening in
-
experiments Design guide RNAs and use CRISPR for gene editing Design AAV vectors for gene therapy on mouse models Capture fluorescent images and quantify data Purify proteins and perform western analyses
-
novel strategies to treat seizures and cytotoxic edema, especially in neonates. To reach this goal, we are addressing the following questions: 1. How does the brain inhibitory system work at the cellular
-
quantitative medical imaging and: 1) image processing of the cardiopulmonary system or 2) a strong epidemiological background allowing them to utilize the output of quantitative imaging methods
-
Documents Curriculum Vita Name and Contact Information of References Letters of Interest Number of References: 2 To start the Online Application process for this position, click the "Apply for This Position
-
will subsequently help us to develop new ligands to specifically treat patients suffering from these common diseases and to develop more precise medications in the future. We will use nanoparticle